title: Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses.
abstract: T-cell infiltrates are robust prognostic biomarkers in the majority of human cancers. However, the mechanisms that shape a protective T-cell response remain unclear. Our recent study implicates tertiary lymphoid structures in the shaping of an efficient and beneficial immune response in lung cancer patients.
authors.affiliation: The Laboratory of Cancer and Immune escape; INSERM U1138; Cordeliers Research Center; Paris, France ; University Pierre and Marie Curie; UMRS1138; Paris, France ; University Paris Descartes; UMRS1138; Paris, France.
authors.forename: Jérémy
authors.initials: J
authors.lastname: Goc
authors.affiliation: The Laboratory of Cancer and Immune escape; INSERM U1138; Cordeliers Research Center; Paris, France ; University Pierre and Marie Curie; UMRS1138; Paris, France ; University Paris Descartes; UMRS1138; Paris, France.
authors.forename: Wolf-Herman
authors.initials: WH
authors.lastname: Fridman
authors.affiliation: Oncology Research, MedImmune, Gaithersburg, Maryland, USA.
authors.forename: Scott A
authors.initials: SA
authors.lastname: Hammond
authors.affiliation: The Laboratory of Cancer and Immune escape; INSERM U1138; Cordeliers Research Center; Paris, France ; University Pierre and Marie Curie; UMRS1138; Paris, France ; University Paris Descartes; UMRS1138; Paris, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Sautès-Fridman
authors.affiliation: The Laboratory of Cancer and Immune escape; INSERM U1138; Cordeliers Research Center; Paris, France ; University Pierre and Marie Curie; UMRS1138; Paris, France ; University Paris Descartes; UMRS1138; Paris, France.
authors.forename: Marie-Caroline
authors.initials: MC
authors.lastname: Dieu-Nosjean
keywords: dendritic cell; lung cancer; tertiary lymphoid structure; tumor immunology; tumor-infiltrating lymphocyte
references.citation: Cancer Res. 2014 Feb 1;74(3):705-15
references.pmid: 24366885
references.citation: Cancer Res. 2011 Oct 15;71(20):6391-9
references.pmid: 21900403
references.citation: Cancer Res. 2012 Aug 15;72(16):3997-4007
references.pmid: 22850419
references.citation: Nat Rev Cancer. 2012 Mar 15;12(4):298-306
references.pmid: 22419253
references.citation: Nature. 2011 Dec 21;480(7378):480-9
references.pmid: 22193102
references.citation: Am J Respir Crit Care Med. 2014 Apr 1;189(7):832-44
references.pmid: 24484236
references.citation: J Immunol. 2013 Aug 15;191(4):2001-8
references.pmid: 23825314
references.citation: J Clin Invest. 2013 Jul;123(7):2873-92
references.pmid: 23778140
references.citation: Oncoimmunology. 2013 Dec 1;2(12):e26836
references.pmid: 24498556
references.citation: Trends Immunol. 2012 Jun;33(6):297-305
references.pmid: 22622061